Two Sigma Advisers’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-663,830	Closed	-$1.83M	–	369
2025 Q4	$1.83M	Buy	663,830 +258,200	+64%	+$737K	﹤0.01%	1225
2025 Q3	$1.39M	Sell	405,630 -89,620	-18%	-$327K	﹤0.01%	1303
2025 Q2	$1.7M	Buy	495,250 +249,800	+102%	+$659K	﹤0.01%	1200
2025 Q1	$523K	Buy	245,450 +93,840	+62%	+$282K	﹤0.01%	1758
2024 Q4	$484K	Buy	+151,610	New	+$1.24M	﹤0.01%	1789
2024 Q2	–	Sell	-2,310	Closed	-$27.5K	–	2464
2024 Q1	$27.5K	Sell	2,310 -930	-29%	-$7.93K	﹤0.01%	2385
2023 Q4	$13K	Sell	3,240 -20	-0.6%	-$56	﹤0.01%	2463
2023 Q3	$8.92K	Sell	3,260 -360	-10%	-$1.68K	﹤0.01%	2347
2023 Q2	$24.2K	Sell	3,620 -560	-13%	-$3.4K	﹤0.01%	2319
2023 Q1	$26.7K	Sell	4,180 -270	-6%	-$1.1K	﹤0.01%	2501
2022 Q4	$11K	Hold	4,450	–	–	﹤0.01%	2456
2022 Q3	$10K	Sell	4,450 -990	-18%	-$3.39K	﹤0.01%	2480
2022 Q2	$17K	Sell	5,440 -1,140	-17%	-$3.48K	﹤0.01%	2561
2022 Q1	$24K	Buy	6,580 +2,620	+66%	+$9.55K	﹤0.01%	2653
2021 Q4	$15K	Buy	+3,960	New	+$21.1K	﹤0.01%	2557
2021 Q2	–	Sell	-5,170	Closed	-$56K	–	2468
2021 Q1	$56K	Buy	+5,170	New	+$78.1K	﹤0.01%	2494